Total planned funding: $533,933,978
Allocations
Countries/Regions
| Kenya | $90,698,809 |
| Mozambique | $82,722,817 |
| South Africa | $73,810,998 |
| Tanzania | $64,110,212 |
| Ethiopia | $37,671,368 |
| Nigeria | $30,544,536 |
| Malawi | $28,642,840 |
| Uganda | $22,546,676 |
| Rwanda | $11,512,503 |
| Asia Regional Program | $11,352,045 |
| Botswana | $10,037,712 |
| Eswatini | $9,506,069 |
| Haiti | $8,777,976 |
| Democratic Republic of the Congo | $7,458,556 |
| Zambia | $7,182,255 |
| Côte d'Ivoire | $6,312,838 |
| Namibia | $6,050,125 |
| Cameroon | $5,094,280 |
| Lesotho | $4,136,579 |
| South Sudan | $3,357,954 |
| Western Hemisphere Region | $2,747,413 |
| Zimbabwe | $2,589,070 |
| Vietnam | $2,547,300 |
| Ukraine | $1,625,000 |
| India | $1,313,011 |
| Angola | $732,856 |
| Burundi | $281,112 |
| Central Asia Region | $241,068 |
| Caribbean Region | $200,000 |
| Guyana | $80,000 |
| China | $50,000 |
Organizational Types
| University | $533,933,978 |
Program Areas
| Treatment | $533,933,978 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $448,247,140 |
| PDTX: Treatment: Pediatric Treatment | $75,265,353 |
| HTXD: Treatment: ARV Drugs | $10,421,485 |
Top Partner Programs
Columbia University:
$202,885,092
View countries
Harvard University:
$51,250,669
View countries
University of Washington:
$41,517,886
View countries
University of the Witwatersrand:
$38,762,023
View countries
Johns Hopkins University:
$37,426,449
View countries